Virica Logo

Virica’s Founder and CEO Dr. Jean-Simon Diallo Spoke with CBC’s All in a Day, Alan Neal

2022-02-04T08:56:53-05:00

Virica’s Founder and CEO Dr. Jean-Simon Diallo spoke in an interview with CBC on All in a Day with Alan Neal on fighting the current COVID-19 pandemic by speeding up the process of mass-producing vaccines. Virica’s VSE technology which was spun out of the Ottawa Hospital Research Institute aims to overcome the manufacturing challenges [...]

Virica’s Founder and CEO Dr. Jean-Simon Diallo Spoke with CBC’s All in a Day, Alan Neal2022-02-04T08:56:53-05:00

Virica’s Founder and CEO Dr. Jean-Simon Diallo interviewed by CTV Ottawa Morning

2022-02-04T08:56:18-05:00

Virica’s Founder and CEO Dr. Jean-Simon Diallo discusses his latest virology research at the Ottawa Hospital Research Institute, which focuses on Covid-19 and is funded by the Ontario Government, with CTV Ottawa Morning. His team is using a biosensor that detects the interaction with the virus and its receptor which will allow them to [...]

Virica’s Founder and CEO Dr. Jean-Simon Diallo interviewed by CTV Ottawa Morning2022-02-04T08:56:18-05:00

Development of Supporting Analytical Assays and Regulatory Compliance Package for Viral Sensitizer Technology Commercialization

2022-02-04T08:56:01-05:00

Virica Biotech is proud to announce a critical $1 million collaborative project with Dr. Jean-Simon Diallo's Ottawa Hospital Research Institute lab that has been selected for grant financing by BioCanRx. The primary deliverable for this project is the generation of a set of regulatory assays and procedures forming a critical path that will enable [...]

Development of Supporting Analytical Assays and Regulatory Compliance Package for Viral Sensitizer Technology Commercialization2022-02-04T08:56:01-05:00

Virica Biotech to Participate in Two Accelerator Programs

2022-02-04T08:55:47-05:00

Virica Biotech is excited to be participating in two accelerator programs: The Global US Market Expansion Accelerator – Global Soft Landing program and the Canadian Entrepreneurs in Life Sciences (CELS) program. These programs provide coaching and enable participating companies to form meaningful relationships with stakeholders, as well as establish a presence in the life [...]

Virica Biotech to Participate in Two Accelerator Programs2022-02-04T08:55:47-05:00

Virica Biotech Participates in BARDA Lightning Talk

2022-02-04T08:55:16-05:00

BARDA selected Virica Biotech to participate in a BARDA Lightning Talk on BARDA Industry Day. Virica was proud to participate and looks forward to connecting with attendees interested in its Viral Sensitizers. Visit the website. Hear from Jean-Simon Diallo, Scientific Founder and CEO, on how our VSE Technology is enhancing manufacturing of vaccines, including [...]

Virica Biotech Participates in BARDA Lightning Talk2022-02-04T08:55:16-05:00
Go to Top